Fortress Biotech, Inc.

The momentum for this stock is not very good. Fortress Biotech, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Fortress Biotech, Inc..
Log in to see more information.
Fortress Biotech, Inc. engages in the development and commercialization of novel pharmaceutical and...

News

Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Globe Newswire MIAMI, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) ( Fortress ), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term...\n more…

Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027
Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027

Globe Newswire Extends maturity of long-term debt as Fortress' late-stage pipeline continues to advance and may generate up to three regulatory approvals on NDAs and BLAs in the next 12 months and potentially a...\n more…

Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

Globe Newswire MIAMI, July 05, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO; FBIOP) ( Fortress ), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance...\n more…